Table 2 |
|||||||
|
Anthropometric Measures at Week 0 and Week 16 |
|||||||
|
Measurement |
Week |
MD Group Mean ± SD |
Within Group Δ p-value |
Week |
FB Group Mean ± SD |
Within Group Δ p-value |
Between Group Δ p-value |
|
|
|||||||
|
Weight (kgs)* |
0 (n = 45) |
111.6 ± 25.7 |
p < 0.0001 |
0 (n = 45) |
104.1 ± 17.1 |
p < 0.0001 |
p = 0.001 |
|
16 (n = 28) |
98.0 ± 23.9 |
16 (n = 20) |
95.4 ± 18.9 |
||||
|
BMI (kg/m2) |
0 (n = 45) |
38.5 ± 6.8 |
p < 0.0001 |
0 (n = 45) |
37.8 ± 4.5 |
p = 0.001 |
p = 0.001 |
|
16 (n = 28) |
33.8 ± 6.6 |
16 (n = 20) |
34.7 ± 5.9 |
||||
|
Waist |
0 (n = 45) |
116.6 ± 15.5 |
p < 0.0001 |
0 (n = 45) |
114.2 ± 15.0 |
p = 0.003 |
p = 0.028 |
|
Circumference (cm) |
16 (n = 26) |
104.5 ± 16.9 |
16 (n = 20) |
104.9 ± 14.9 |
|||
|
Body Fat (%)* |
0 (n = 45) |
42.8 ± 7.7 |
p < 0.0001 |
0(n = 45) |
44.1 ± 6.4 |
p = 0.268 |
p < 0.0001 |
|
16 (n = 27) |
37.5 ± 8.8 |
16 (n = 20) |
41.0 ± 7.6 |
||||
|
Lean Muscle |
0 (n = 41) |
56.8 ± 11.4 |
p < 0.0001 |
0 (n = 41) |
53.3 ± 8.7 |
p = 0.003 |
p = 0.56 |
|
Mass (kgs) |
16 (n = 25) |
55.0 ± 10.4 |
16 (n = 20) |
52.8 ± 9.4 |
|||
|
Visceral Fat |
0 (n = 41) |
13.8 ± 3.8 |
p < 0.0001 |
0 (n = 41) |
13.7 ± 5.0 |
p = 0.081 |
p < 0.0001 |
|
Rating |
16 (n = 25) |
10.6 ± 3.5 |
16 (n = 20) |
14.2 ± 6.1 |
|||
|
Systolic BP |
0 (n = 45) |
125.4 ± 13.9 |
p < 0.0001 |
0 (n = 45) |
125.8 ± 13.6 |
p = 0.003 |
p = 0.667 |
|
(mmHg) |
16 (n = 28) |
113.6 ± 14.3 |
16 (n = 20) |
115.8 ± 12.3 |
|||
|
Diastolic BP |
0 (n = 45) |
83.2 ± 9.5 |
p = 0.001 |
0 (n = 45) |
82.6 ± 10.2 |
p = 0.016 |
p = 0.622 |
|
(mmHg) |
16 (n = 28) |
74.2 ± 8.8 |
16 (n = 20) |
74.2 ± 6.8 |
|||
|
Pulse, |
0 (n = 45) |
76.4 ± 9.3 |
p = 0.001 |
0 (n = 45) |
73.9 ± 9.2 |
p = 0.011 |
p = 0.112 |
|
(bpm) |
16 (n = 26) |
67.2 ± 8.6 |
16 (n = 19) |
71.2 ± 8.1 |
|||
|
|
|||||||
|
Δ = Change from baseline to 16 weeks. * = Primary outcomes. All others are secondary outcomes. |
|||||||
|
Davis et al. Nutrition Journal 2010 9:11 doi:10.1186/1475-2891-9-11 |
|||||||
